theralase_logo_destroying_cancer.png
Theralase Expands Intellectual Property Portfolio
09 déc. 2021 07h00 HE | Theralase Technologies Inc.
TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
theralase_logo_destroying_cancer.png
Theralase Releases 3Q21 Financial Statements and Newsletter
29 nov. 2021 18h00 HE | Theralase Technologies Inc.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
theralase_logo_destroying_cancer.png
Theralase Announces Leadership Reorganization
15 nov. 2021 16h25 HE | Theralase Technologies Inc.
TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Study II Clinical Data (Preliminary)*
Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter
30 août 2021 18h15 HE | Theralase Technologies Inc.
TORONTO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), A clinical stage pharmaceutical company dedicated to the research...
theralase_logo_destroying_cancer.png
Theralase Announces Leadership Transition
19 août 2021 16h49 HE | Theralase Technologies Inc.
TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
theralase_logo_destroying_cancer.png
Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US
11 juin 2021 07h00 HE | Theralase Technologies Inc.
TORONTO, June 11, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
Theralase Releases Q12021 Interim Financial Statements
28 mai 2021 18h58 HE | Theralase Technologies Inc.
TORONTO, May 28, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research...
theralase_logo_destroying_cancer.png
Theralase Technologies Inc. (TLT) to Present at the Small-Cap Stars Spring Conference 2015 at Convene in Times Square New York on June 10
04 juin 2015 08h00 HE | Theralase Technologies Inc.
NEW YORK, June 4, 2015 (GLOBE NEWSWIRE) -- Theralase Technologies Inc. (TSX-V:TLT), a designer, developer, manufacturer and marketer of laser technology, will be presenting at the Small-Cap Stars...